Carcinomas of the Head and Neck:Evaluation and Management

图书简介

It was not too many years ago that the role of chemotherapy for head and neck cancer consisted of single-agent methotrexate for selected patients with recurrent disease. In the past decade, multiple new agents, high-dose chemotherapy, combinations, and intra-arterial approaches have been used for the patient with recurrent disease. Wheeler critically assesses the current status of these approaches. When oncologists began testing chemotherapy in the combined modality approach, trials consisted of induction chemotherapy and use of single agents as radiosensitizers. Although a great deal has been learned from these trials, benefit in terms of survival has been marginal. Even more promising may be the concomitant use of combination chemo therapy and radiation. Taylor describes the encouraging results as well as the potential. Induction chemotherapy may have a second important goal in addition to improving curability-it could be used for organ preservation. Dimery et al., present the background for this approach in the patient with laryngeal cancer as well as a description of their randomized trial for voice preservation. Head and neck squamous cancers are a heterogeneous group of diseases, and surgeons have long sought parameters that will help predict outcome.

I. Advances in Staging and Primary Treatment.- 1. Magnetic Resonance Imaging of Head and Neck Cancer.- 2. Diagnostic Imaging in the Diagnosis of Malignant Invasion of the Carotid Artery: Ultrasound, Computed Tomography, Magnetic Resonance Imaging.- 3. Craniofacial Resection for Tumors of the Ethmoid and Superior Nasal Vault.- 4. Surgical Resection for Recurrent Nasopharynx Cancer.- 5. Advanced Basal and Squamous Cell Carcinomas of the Head and Neck.- 6. Interstitial Hyperthermia in Head and Neck Oncology.- 7. Photodynamic Therapy in the Management of Head and Neck Cancer.- II. Rehabilitation.- 8. Mechanisms for Vocal Communication Following Total Laryngectomy.- 9. Neck Dissection: Morbidity and Rehabilitation.- III. Advances in Medical Management and Chemotherapeutic Approaches.- 10. Evaluation and Medical Management of Thyroid Cancer.- 11. Chemotherapy of Patients with Recurrent Head and Neck Cancer.- 12. Combined Chemotherapy and Radiation for Unresectable Head and Neck Cancer.- 13. The Role of Induction Chemotherapy for Organ Preservation in Laryngeal Carcinoma.- IV. Basic Biology and Etiology.- 14. Methodology and Clinical Applications of Cellular DNA Content Parameters Determined by Flow Cytometry in Squamous Cell Cancers of the Head and Neck.- 15. Head and Neck Tumor Immunology II. Humoral Immunity.- 16. Etiologic Considerations for Head and Neck Squamous Cancers.

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Carcinomas of the Head and Neck:Evaluation and Management（Cancer Treatment and Research） 肿瘤学

Carcinomas of the Head and Neck:Evaluation and Management（Cancer Treatment and Research）
肿瘤学